Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Intense competition from Viking Therapeutics and Amgen, may result in a new best in class GLP-1 drug, further threatening ... but as can be seen in the above chart they are relatively negligible ...